Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 01-Oct-20 5:18 PM View:  | Stoner Elizabeth Director | Momenta Pharmaceuticals Inc. (MNTA) | 01-Oct-20 | Disposition | 35,509 | -- | -- | (100%) 35.51K to 0 | |
| 01-Oct-20 4:55 PM View: | Wheeler Craig A President & CEO Director | Momenta Pharmaceuticals Inc. (MNTA) | 01-Oct-20 | Disposition | 8,739 | -- | -- | (2%) 482.85K to 474.11K | |
| 01-Oct-20 4:56 PM View: | Arroyo Santiago SVP, Chief Medical Officer | Momenta Pharmaceuticals Inc. (MNTA) | 01-Oct-20 | Disposition | 26 | -- | -- | (100%) 26 to 0 | |
| 01-Oct-20 5:10 PM View: | Downey Bruce Director | Momenta Pharmaceuticals Inc. (MNTA) | 01-Oct-20 | Disposition | 41,844 | -- | -- | (100%) 41.84K to 0 | |
| 01-Oct-20 5:14 PM View: | Gilman Steven C Director | Momenta Pharmaceuticals Inc. (MNTA) | 01-Oct-20 | Disposition | 7,796 | -- | -- | (100%) 7.8K to 0 | |
| 01-Oct-20 4:55 PM View: | Wheeler Craig A President & CEO Director | Momenta Pharmaceuticals Inc. (MNTA) | 01-Oct-20 | Disposition | 474,108 | -- | -- | (100%) 474.11K to 0 | |
| 01-Oct-20 4:58 PM View: | Beltramello Jo Ann Chief HR and Inf. Officer | Momenta Pharmaceuticals Inc. (MNTA) | 01-Oct-20 | Disposition | 57,157 | -- | -- | (100%) 57.16K to 0 | |
| 01-Oct-20 5:01 PM View: | Cieplinska Agnieszka Chief Accounting Officer (PAO) | Momenta Pharmaceuticals Inc. (MNTA) | 01-Oct-20 | Disposition | 8,136 | -- | -- | (100%) 8.14K to 0 | |
| 01-Oct-20 5:07 PM View: | Manning Anthony M. Chief Scientific Officer | Momenta Pharmaceuticals Inc. (MNTA) | 01-Oct-20 | Disposition | 12,778 | -- | -- | (100%) 12.78K to 0 | |
| 01-Oct-20 5:00 PM View: | Carvajal Alejandra Chief Legal Officer | Momenta Pharmaceuticals Inc. (MNTA) | 01-Oct-20 | Disposition | 28,795 | -- | -- | (100%) 28.8K to 0 | |
| 01-Oct-20 5:05 PM View: | Kwon Young Chief Financial & Bus. Officer | Momenta Pharmaceuticals Inc. (MNTA) | 01-Oct-20 | Disposition | 160,633 | -- | -- | (100%) 160.63K to 0 | |
| 01-Oct-20 5:12 PM View: | Gemayel Georges Director | Momenta Pharmaceuticals Inc. (MNTA) | 01-Oct-20 | Disposition | 14,090 | -- | -- | (100%) 14.09K to 0 | |
| 01-Oct-20 4:55 PM View: | Wheeler Craig A President & CEO Director | Momenta Pharmaceuticals Inc. (MNTA) | 10-Sep-20 | Gift | 190,476 | -- | -- | (28%) 673.32K to 482.85K | |
| 21-Aug-20 4:55 PM View: | Fier Ian Chief Mfg and Program Officer | Momenta Pharmaceuticals Inc. (MNTA) | 20-Aug-20 | Private Sale (Planned) | 383 | $52.17 | $19,981.10 | (100%) 0.38K to 0 | |
| 21-Aug-20 4:55 PM View: | Fier Ian Chief Mfg and Program Officer | Momenta Pharmaceuticals Inc. (MNTA) | 20-Aug-20 | Planned Private Option Sale | 1,425 | $52.17 | $74,342.20 | (79%) 1.81K to 0.38K | |
| 21-Aug-20 4:55 PM View: | Fier Ian Chief Mfg and Program Officer | Momenta Pharmaceuticals Inc. (MNTA) | 20-Aug-20 | Option Exercise | 1,425 | $18.85 | $26,861.20 | 372% 0.38K to 1.81K | |
| 20-Aug-20 6:19 PM View: | Guiterrez-Ramos Jose Carlos Director | Momenta Pharmaceuticals Inc. (MNTA) | 19-Aug-20 | Planned Private Option Sale | 10,000 | $52.09 | $520,900.00 | (100%) 10.0K to 0 | |
| 20-Aug-20 6:19 PM View: | Guiterrez-Ramos Jose Carlos Director | Momenta Pharmaceuticals Inc. (MNTA) | 19-Aug-20 | Option Exercise | 10,000 | $8.59 | $85,900.00 | 100% 0 to 10.0K | |
| 13-Aug-20 5:47 PM View: | Wheeler Craig A President & CEO Director | Momenta Pharmaceuticals Inc. (MNTA) | 13-Aug-20 | Planned Private Option Sale | 2,777 | $28.55 | $79,283.40 | (< 1%) 676.1K to 673.32K | |
| 13-Aug-20 7:46 PM View: | Manning Anthony M. Chief Scientific Officer | Momenta Pharmaceuticals Inc. (MNTA) | 13-Aug-20 | Private Sale (Planned) | 403 | $29.31 | $11,813.10 | (3%) 13.18K to 12.78K | |
| 13-Aug-20 4:58 PM View: | Beltramello Jo Ann Chief HR and Inf. Officer | Momenta Pharmaceuticals Inc. (MNTA) | 12-Aug-20 | Private Sale (Planned) | 673 | $27.88 | $18,763.20 | (< 1%) 121.91K to 121.24K | |
| 13-Aug-20 5:47 PM View: | Wheeler Craig A President & CEO Director | Momenta Pharmaceuticals Inc. (MNTA) | 12-Aug-20 | Option Exercise | 6,171 | -- | -- | < 1% 669.93K to 676.1K | |
| 13-Aug-20 4:58 PM View: | Beltramello Jo Ann Chief HR and Inf. Officer | Momenta Pharmaceuticals Inc. (MNTA) | 11-Aug-20 | Option Exercise | 6,250 | $12.76 | $79,750.00 | 5% 121.91K to 128.16K | (5%) |
| 13-Aug-20 4:58 PM View: | Beltramello Jo Ann Chief HR and Inf. Officer | Momenta Pharmaceuticals Inc. (MNTA) | 11-Aug-20 | Planned Private Option Sale | 6,250 | $28.03 | $175,188.00 | (5%) 128.16K to 121.91K | |
| 11-Aug-20 4:40 PM View: | Wheeler Craig A President & CEO Director | Momenta Pharmaceuticals Inc. (MNTA) | 10-Aug-20 | Planned Private Option Sale | 2,601 | $31.21 | $81,177.20 | (< 1%) 672.53K to 669.93K | |
| 11-Aug-20 4:42 PM View: | Manning Anthony M. Chief Scientific Officer | Momenta Pharmaceuticals Inc. (MNTA) | 10-Aug-20 | Planned Private Option Sale | 347 | $32.36 | $11,228.90 | (3%) 13.53K to 13.18K | |
| 11-Aug-20 4:41 PM View: | Kwon Young Chief Financial & Bus. Officer | Momenta Pharmaceuticals Inc. (MNTA) | 10-Aug-20 | Planned Private Option Sale | 652 | $32.36 | $21,098.70 | (< 1%) 161.28K to 160.63K | |
| 11-Aug-20 4:41 PM View: | Fier Ian Chief Mfg and Program Officer | Momenta Pharmaceuticals Inc. (MNTA) | 10-Aug-20 | Planned Private Option Sale | 330 | $32.36 | $10,678.80 | (46%) 0.71K to 0.38K | |
| 11-Aug-20 4:40 PM View: | Beltramello Jo Ann Chief HR and Inf. Officer | Momenta Pharmaceuticals Inc. (MNTA) | 10-Aug-20 | Planned Private Option Sale | 622 | $32.36 | $20,127.90 | (< 1%) 118.25K to 117.63K | |
| 11-Aug-20 4:40 PM View: | Beltramello Jo Ann Chief HR and Inf. Officer | Momenta Pharmaceuticals Inc. (MNTA) | 07-Aug-20 | Planned Private Option Sale | 2,690 | $32.00 | $86,080.00 | (2%) 120.94K to 118.25K | |
| 11-Aug-20 4:41 PM View: | Kwon Young Chief Financial & Bus. Officer | Momenta Pharmaceuticals Inc. (MNTA) | 07-Aug-20 | Option Exercise | 1,410 | -- | -- | < 1% 159.88K to 161.28K | |
| 11-Aug-20 4:40 PM View: | Beltramello Jo Ann Chief HR and Inf. Officer | Momenta Pharmaceuticals Inc. (MNTA) | 07-Aug-20 | Option Exercise | 2,690 | $18.85 | $50,706.50 | 2% 118.25K to 120.94K | |
| 11-Aug-20 4:40 PM View: | Wheeler Craig A President & CEO Director | Momenta Pharmaceuticals Inc. (MNTA) | 07-Aug-20 | Option Exercise | 5,781 | -- | -- | < 1% 666.75K to 672.53K | |
| 11-Aug-20 4:41 PM View: | Fier Ian Chief Mfg and Program Officer | Momenta Pharmaceuticals Inc. (MNTA) | 07-Aug-20 | Option Exercise | 713 | -- | -- | 100% 0 to 0.71K | |
| 11-Aug-20 4:40 PM View: | Beltramello Jo Ann Chief HR and Inf. Officer | Momenta Pharmaceuticals Inc. (MNTA) | 07-Aug-20 | Option Exercise | 1,346 | -- | -- | 1% 116.9K to 118.25K | |
| 11-Aug-20 4:42 PM View: | Manning Anthony M. Chief Scientific Officer | Momenta Pharmaceuticals Inc. (MNTA) | 07-Aug-20 | Option Exercise | 750 | -- | -- | 6% 12.78K to 13.53K | |
| 07-Aug-20 5:04 PM View: | Gilman Steven C Director | Momenta Pharmaceuticals Inc. (MNTA) | 05-Aug-20 | Planned Private Option Sale | 13,000 | $32.75 | $425,750.00 | (63%) 20.8K to 7.8K | |
| 07-Aug-20 4:48 PM View: | Gemayel Georges Director | Momenta Pharmaceuticals Inc. (MNTA) | 05-Aug-20 | Option Exercise | 10,000 | $14.84 | $148,400.00 | 71% 14.09K to 24.09K | |
| 07-Aug-20 5:04 PM View: | Gilman Steven C Director | Momenta Pharmaceuticals Inc. (MNTA) | 05-Aug-20 | Option Exercise | 13,000 | $10.63 | $138,190.00 | 167% 7.8K to 20.8K | |
| 06-Aug-20 4:19 PM View: | Arroyo Santiago SVP, Chief Medical Officer | Momenta Pharmaceuticals Inc. (MNTA) | 05-Aug-20 | Private Sale (Planned) | 94 | $32.65 | $3,069.10 | (100%) 94 to 0 | |
| 07-Aug-20 4:48 PM View: | Gemayel Georges Director | Momenta Pharmaceuticals Inc. (MNTA) | 05-Aug-20 | Planned Private Option Sale | 10,000 | $33.00 | $330,000.00 | (42%) 24.09K to 14.09K | |
| 06-Aug-20 4:18 PM View: | Fier Ian Chief Mfg and Program Officer | Momenta Pharmaceuticals Inc. (MNTA) | 04-Aug-20 | Planned Private Option Sale | 24,969 | $32.76 | $817,984.00 | (100%) 24.97K to 0 | |
| 06-Aug-20 4:19 PM View: | Arroyo Santiago SVP, Chief Medical Officer | Momenta Pharmaceuticals Inc. (MNTA) | 04-Aug-20 | Planned Private Option Sale | 32,656 | $32.25 | $1,053,160.00 | (94%) 34.64K to 1.98K | |
| 06-Aug-20 4:18 PM View: | Fier Ian Chief Mfg and Program Officer | Momenta Pharmaceuticals Inc. (MNTA) | 04-Aug-20 | Option Exercise | 24,969 | $12.76 | $318,604.00 | 100% 0 to 24.97K | (5%) |
| 06-Aug-20 4:19 PM View: | Arroyo Santiago SVP, Chief Medical Officer | Momenta Pharmaceuticals Inc. (MNTA) | 04-Aug-20 | Private Sale (Planned) | 1,886 | $32.25 | $60,823.50 | (95%) 1.98K to 94 | |
| 06-Aug-20 4:19 PM View: | Arroyo Santiago SVP, Chief Medical Officer | Momenta Pharmaceuticals Inc. (MNTA) | 04-Aug-20 | Option Exercise | 32,656 | $15.82 | $516,591.00 | 1649% 1.98K to 34.64K | |
| 30-Jul-20 7:03 PM View: | Gilman Steven C Director | Momenta Pharmaceuticals Inc. (MNTA) | 29-Jul-20 | Option Exercise | 10,000 | $10.63 | $106,300.00 | 128% 7.8K to 17.8K | |
| 30-Jul-20 7:29 PM View: | Arroyo Santiago SVP, Chief Medical Officer | Momenta Pharmaceuticals Inc. (MNTA) | 29-Jul-20 | Planned Private Option Sale | 32,656 | $30.00 | $979,680.00 | (79%) 41.5K to 8.85K | |
| 30-Jul-20 7:03 PM View: | Gemayel Georges Director | Momenta Pharmaceuticals Inc. (MNTA) | 29-Jul-20 | Planned Private Option Sale | 10,000 | $30.00 | $300,000.00 | (42%) 24.09K to 14.09K | |
| 30-Jul-20 7:29 PM View: | Arroyo Santiago SVP, Chief Medical Officer | Momenta Pharmaceuticals Inc. (MNTA) | 29-Jul-20 | Option Exercise | 32,656 | $15.82 | $516,591.00 | 369% 8.85K to 41.5K |
